Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis

Technology appraisal guidance
Reference number: TA308
Published: 26 March 2014

Vasculitis (anti-neutrophil cytoplasmic antibody-associated) - rituximab (with glucocorticoids): final appraisal determination document

Vasculitis (anti-neutrophil cytoplasmic antibody-associated) - rituximab (with glucocorticoids): final appraisal determination document

Vasculitis (anti-neutrophil cytoplasmic antibody-associated) - rituximab (with glucocorticoids): final appraisal determination document
24 January 2014
(515.28 Kb 30 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 24 January 2014